Find a Research Study

Displaying 1 - 10 of 17

CAPE

To evaluate long-term safety of Humira in pediatric patients (between the ages of 6 and 17 years inclusive at the time of enrollment) with moderately to severely active CD who are prescribed and treated in accordance with the approved local Humira product label under the conditions of routine clinical setting.

ImproveCareNow (ICN)

To improve patient care and achieve the best health outcomes possible for children with IBD.

Phase I Temsirolimus

To test a new experimental drug Temisirolimus - Temsirolimus (also known as Torisel®) is approved for kidney cell cancer treatment in adults - in combination with approved chemotherapy drugs - in the hopes of finding a drug combination that may be effective against leukemia and non-hodgkin’s lymphoma that has come back after initial treatment. To find the highest dose that can be given without casing severe side effects.

SuperHEROES

To find out the effects of a chemical in Stevia on the symptoms of NAFLD.